Northern Trust Corp Ptc Therapeutics, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 658,459 shares of PTCT stock, worth $24.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

658,459

Previous 675,001 2.45%

Holding current value

$24.8 Million

Previous $19.6 Million 2.55%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $408,421 - $663,665	-16,542 Reduced 2.45%	658,459 $20.1 Million
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $334,380 - $442,379	-13,846 Reduced 2.01%	675,001 $19.6 Million
Q4 2023 Feb 13, 2024	SELL	$18.07 - $29.37 $42,392 - $68,902	-2,346 Reduced 0.34%	688,847 $19 Million
Q3 2023 Nov 13, 2023	BUY	$22.41 - $41.99 $113,417 - $212,511	5,061 Added 0.74%	691,193 $15.5 Million
Q2 2023 Aug 11, 2023	BUY	$40.4 - $59.1 $1.18 Million - $1.73 Million	29,269 Added 4.46%	686,132 $27.9 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $196,523 - $251,629	5,150 Added 0.79%	656,863 $31.8 Million
Q4 2022 Feb 13, 2023	BUY	$33.53 - $54.79 $137,540 - $224,748	4,102 Added 0.63%	651,713 $24.9 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $333,042 - $428,538	-7,958 Reduced 1.21%	647,611 $32.5 Million
Q2 2022 Aug 12, 2022	SELL	$25.6 - $45.23 $428,902 - $757,783	-16,754 Reduced 2.49%	655,569 $26.3 Million
Q1 2022 May 13, 2022	SELL	$33.33 - $44.6 $1.21 Million - $1.62 Million	-36,300 Reduced 5.12%	672,323 $25.1 Million
Q4 2021 Feb 08, 2022	SELL	$35.36 - $41.86 $203,602 - $241,029	-5,758 Reduced 0.81%	708,623 $28.2 Million
Q3 2021 Nov 15, 2021	SELL	$37.01 - $44.74 $781,096 - $944,237	-21,105 Reduced 2.87%	714,381 $26.6 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $211,305 - $274,892	5,568 Added 0.76%	735,486 $31.1 Million
Q1 2021 May 12, 2021	SELL	$46.8 - $68.92 $2.26 Million - $3.33 Million	-48,389 Reduced 6.22%	729,918 $34.6 Million
Q4 2020 Feb 11, 2021	SELL	$47.96 - $67.64 $1.12 Million - $1.58 Million	-23,290 Reduced 2.91%	778,307 $47.5 Million
Q3 2020 Nov 16, 2020	SELL	$45.41 - $57.07 $1.71 Million - $2.15 Million	-37,747 Reduced 4.5%	801,597 $37.5 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $2.32 Million - $3 Million	54,583 Added 6.96%	839,344 $42.6 Million
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $615,515 - $1.13 Million	19,015 Added 2.48%	784,761 $35 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $280,958 - $436,610	8,720 Added 1.15%	765,746 $36.8 Million
Q3 2019 Nov 13, 2019	BUY	$33.82 - $48.17 $2.53 Million - $3.6 Million	74,794 Added 10.96%	757,026 $25.6 Million
Q2 2019 Aug 13, 2019	BUY	$35.42 - $45.0 $441,120 - $560,430	12,454 Added 1.86%	682,232 $30.7 Million
Q1 2019 May 13, 2019	BUY	$28.09 - $39.49 $2.23 Million - $3.14 Million	79,551 Added 13.48%	669,778 $25.2 Million
Q4 2018 Feb 12, 2019	SELL	$29.83 - $46.51 $5.13 Million - $8 Million	-172,111 Reduced 22.58%	590,227 $20.3 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $862,619 - $1.22 Million	25,446 Added 3.45%	762,338 $35.8 Million
Q2 2018 Sep 18, 2018	SELL	$25.7 - $47.88 $70,546 - $131,430	-2,745 Reduced 0.37%	736,892 $24.9 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $1.91 Million - $3.57 Million	74,501 Added 11.2%	739,637 $24.9 Million
Q1 2018 May 09, 2018	SELL	$17.46 - $32.59 $44,016 - $82,159	-2,521 Reduced 0.38%	665,136 $18 Million
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $144,935 - $199,979	-9,573 Reduced 1.41%	667,657 $11.1 Million
Q3 2017 Nov 13, 2017	BUY	$16.81 - $21.61 $11.4 Million - $14.6 Million	677,230	677,230 $13.6 Million

Others Institutions Holding PTCT

# of Institutions

215

Shares Held

79.2M

Call Options Held

122K

Put Options Held

212K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Ptc Therapeutics, Inc. Transaction History